FDA Delays Release of Guidance on Biomarker Qualification; Aims to Publish by End of Year

Originally slated to be released this summer, the guidance will detail the formal steps involved in qualifying biomarkers for FDA approval.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.